CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent 5-Year Outcomes of the Randomized BIOFLOW-II Trial Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Poor R-wave progression as a predictor of sudden cardiac death in general population and subjects with coronary artery disease Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

Review Article2017 Nov;5(11):763-771.

JOURNAL:JACC Heart Fail. Article Link

Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions

Hsu JJ, Ziaeian B, Fonarow GC. Keywords: HFbEF; HFmrEF; HFpEF; epidemiology; heart failure with borderline ejection fraction; heart failure with mid-range ejection fraction; heart failure with preserved ejection fraction; outcomes

FULL TEXT PDF